U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Endometrial Mixed Cell Adenocarcinoma

MedGen UID:
1663352
•Concept ID:
C4744400
•
Neoplastic Process
Synonym: Recurrent Endometrial Mixed Epithelial Carcinoma

Definition

The reemergence of endometrial mixed cell adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Endometrial Mixed Cell Adenocarcinoma

Professional guidelines

PubMed

The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
Orellana TJ, Garrett AA, Soong TR, Rives T, Courtney-Brooks M, Taylor SE, Lesnock J, Berger J, Boisen M, Coffman L, Buckanovich R, Mahdi H, Comerci JC, Beriwal S, Sukumvanich P, Edwards RP, Bhargava R, Olawaiye AB
Gynecol Oncol 2023 Mar;170:77-83. Epub 2023 Jan 13 doi: 10.1016/j.ygyno.2022.12.024. PMID: 36641903
Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, Fleming ND
Gynecol Oncol 2019 Aug;154(2):328-332. Epub 2019 Jun 18 doi: 10.1016/j.ygyno.2019.06.001. PMID: 31221496Free PMC Article
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V
Int J Gynecol Cancer 2016 Mar;26(3):497-504. doi: 10.1097/IGC.0000000000000635. PMID: 26825840Free PMC Article

Recent clinical studies

Etiology

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
Jeans EB, Breen WG, Mullikin TC, Looker BA, Mariani A, Keeney GL, Haddock MG, Petersen IA
Int J Gynecol Cancer 2021 Jun;31(6):859-867. Epub 2021 Feb 9 doi: 10.1136/ijgc-2020-002217. PMID: 33563642Free PMC Article
How do different histologic components of mixed endometrial carcinomas affect prognosis? Does it really matter?
Thomakos N, Dimopoulou S, Sotiropoulou M, Machairiotis N, Pandraklakis A, Haidopoulos D, Liontos M, Bamias A, Rodolakis A
Horm Mol Biol Clin Investig 2020 Dec 18;42(1):105-111. doi: 10.1515/hmbci-2020-0042. PMID: 33781006
Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN, Natarajan S, Hwang-Graziano JM
Am J Clin Oncol 2018 Apr;41(4):371-378. doi: 10.1097/COC.0000000000000277. PMID: 26950465
Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G, Secomandi R, Parazzini F, Viganò R, Mangili G, Frigerio L, Villa A, Tateo S, Ricci E, Bolis G
Arch Gynecol Obstet 2013 Feb;287(2):351-6. Epub 2012 Oct 26 doi: 10.1007/s00404-012-2586-x. PMID: 23100038
Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB, Zubovits JT, Young RH, Scully RE
Int J Gynecol Pathol 1998 Jul;17(3):211-22. PMID: 9656116

Diagnosis

Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Al-Maghrabi JA, Butt NS, Anfinan N, Sait K, Sait H, Marzouki A, Khabaz MN
Appl Immunohistochem Mol Morphol 2017 Oct;25(9):632-638. doi: 10.1097/PAI.0000000000000350. PMID: 26945446
Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients.
Ye S, You Y, Yang J, Cao D, Bai H, Huang H, Wu M, Chen J, Lang J, Shen K
Int J Gynecol Cancer 2014 Nov;24(9):1590-6. doi: 10.1097/IGC.0000000000000275. PMID: 25254564
Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G, Secomandi R, Parazzini F, Viganò R, Mangili G, Frigerio L, Villa A, Tateo S, Ricci E, Bolis G
Arch Gynecol Obstet 2013 Feb;287(2):351-6. Epub 2012 Oct 26 doi: 10.1007/s00404-012-2586-x. PMID: 23100038
Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA
Am J Surg Pathol 2012 Dec;36(12):1771-81. doi: 10.1097/PAS.0b013e318273591a. PMID: 23154767
Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB, Zubovits JT, Young RH, Scully RE
Int J Gynecol Pathol 1998 Jul;17(3):211-22. PMID: 9656116

Therapy

Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial.
Leung E, Gladwish AP, Davidson M, Taggar A, Velker V, Barnes E, Mendez L, Donovan E, Gien LT, Covens A, Vicus D, Kupets R, MacKay H, Han K, Cheung P, Zhang L, Loblaw A, D'Souza DP
JAMA Oncol 2022 Jun 1;8(6):1-9. doi: 10.1001/jamaoncol.2022.0362. PMID: 35420695Free PMC Article
Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A, Buscariollo D, Alban G, Buzurovic I, Cheng T, Pretz J, Krechmer B, King M, Lee L
Int J Gynecol Cancer 2020 Dec;30(12):1908-1914. Epub 2020 Jul 12 doi: 10.1136/ijgc-2020-001623. PMID: 32655012
Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Volgger B, Zeimet AG, Reinthaller A, Petru E, Schauer C, Klein M, Sevelda-Schwarzgruber U, Bogner G, Wolfram G, Marth C
Int J Gynecol Cancer 2015 Feb;25(2):257-62. doi: 10.1097/IGC.0000000000000352. PMID: 25611899
Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT, Rotmensch J, Yamada SD, Mundt AJ
Int J Radiat Oncol Biol Phys 2003 Apr 1;55(5):1272-6. doi: 10.1016/s0360-3016(02)04404-8. PMID: 12654437
Gynecologic tumors in tamoxifen-treated women with breast cancer.
Seoud MA, Johnson J, Weed JC Jr
Obstet Gynecol 1993 Aug;82(2):165-9. PMID: 8393156

Prognosis

How do different histologic components of mixed endometrial carcinomas affect prognosis? Does it really matter?
Thomakos N, Dimopoulou S, Sotiropoulou M, Machairiotis N, Pandraklakis A, Haidopoulos D, Liontos M, Bamias A, Rodolakis A
Horm Mol Biol Clin Investig 2020 Dec 18;42(1):105-111. doi: 10.1515/hmbci-2020-0042. PMID: 33781006
Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN, Natarajan S, Hwang-Graziano JM
Am J Clin Oncol 2018 Apr;41(4):371-378. doi: 10.1097/COC.0000000000000277. PMID: 26950465
Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G, Secomandi R, Parazzini F, Viganò R, Mangili G, Frigerio L, Villa A, Tateo S, Ricci E, Bolis G
Arch Gynecol Obstet 2013 Feb;287(2):351-6. Epub 2012 Oct 26 doi: 10.1007/s00404-012-2586-x. PMID: 23100038
Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA
Am J Surg Pathol 2012 Dec;36(12):1771-81. doi: 10.1097/PAS.0b013e318273591a. PMID: 23154767
Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB, Zubovits JT, Young RH, Scully RE
Int J Gynecol Pathol 1998 Jul;17(3):211-22. PMID: 9656116

Clinical prediction guides

Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN, Natarajan S, Hwang-Graziano JM
Am J Clin Oncol 2018 Apr;41(4):371-378. doi: 10.1097/COC.0000000000000277. PMID: 26950465
Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.
Rossi ED, Bizzarro T, Monterossi G, Inzani F, Fanfani F, Scambia G, Zannoni GF
Hum Pathol 2017 Apr;62:99-107. Epub 2016 Dec 30 doi: 10.1016/j.humpath.2016.12.015. PMID: 28041971
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Al-Maghrabi JA, Butt NS, Anfinan N, Sait K, Sait H, Marzouki A, Khabaz MN
Appl Immunohistochem Mol Morphol 2017 Oct;25(9):632-638. doi: 10.1097/PAI.0000000000000350. PMID: 26945446
Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G, Secomandi R, Parazzini F, Viganò R, Mangili G, Frigerio L, Villa A, Tateo S, Ricci E, Bolis G
Arch Gynecol Obstet 2013 Feb;287(2):351-6. Epub 2012 Oct 26 doi: 10.1007/s00404-012-2586-x. PMID: 23100038
Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA
Am J Surg Pathol 2012 Dec;36(12):1771-81. doi: 10.1097/PAS.0b013e318273591a. PMID: 23154767

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...